Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health...
Read More
Support for continued progress is critical for pediatric drug development

Researching and developing new medicines for children is a priority for the biopharmaceutical industry. Despite the scientific complexity and challenges inherent to developing treatments for our...
Read More
New Report: More than 400 medicines in development for leading chronic conditions affecting older Americans

Chronic diseases like Alzheimer’s disease, diabetes and kidney disease disproportionately affect older adults. In the United States, nearly 95% of older adults have at least one chronic condition and...
Read More
State policymakers can protect American innovation and help Americans live longer, healthier lives

For the second year in a row, life expectancy is on the decline in America. The leading causes of death across the United States include cancer and chronic diseases. Even when patients are able to...
Read More
Recognizing National Glaucoma Awareness Month

January was National Glaucoma Awareness Month and provided us an opportunity to spread the word and honor the millions of patients around the world who are impacted by this debilitating disease. ...
Read More
New Report: More than 160 medicines in development for mental illness

Mental illness represents a broad spectrum of health conditions affecting mood, thinking and behavior. These conditions include depression, bipolar disorder, schizophrenia, substance use disorder,...
Read More
ICYMI: Cancer death rate continues to decline due to treatment advances

Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to...
Read More
Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

The biopharmaceutical industry is one of the most research-intensive of all sectors in the U.S. economy and supports a broad range of STEM jobs through R&D and manufacturing. At the backbone of the...
Read More
New Report: Nearly 800 medicines in development to treat chronic conditions

Chronic conditions impose a substantial health and economic burden that affects millions of patients, families and communities across the United States each day. While these conditions come with...
Read More
Recognizing National Sickle Cell Awareness Month

September is National Sickle Cell Awareness Month and a time for us to underscore the biopharmaceutical industry’s ongoing commitment to improve the lives of patients, families and communities...
Read More